Ivd Medical Holding
Ivd Medical Holding, a prominent player in the in vitro diagnostics (IVD) industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 2005, the company has established itself as a leader in the development and manufacturing of innovative diagnostic solutions, catering to hospitals, laboratories, and healthcare providers. Specialising in a diverse range of products, Ivd Medical Holding offers unique diagnostic kits and equipment that enhance accuracy and efficiency in medical testing. Their commitment to quality and technological advancement has positioned them favourably in the competitive IVD market. With a focus on research and development, the company has achieved significant milestones, including numerous certifications and partnerships that underscore its reputation for excellence in the healthcare sector.
DitchCarbon Score
How does Ivd Medical Holding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ivd Medical Holding's score of 4 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ivd Medical Holding's reported carbon emissions
In 2023, IVD Medical Holding reported total carbon emissions of approximately 3,859,110 kg CO2e. This figure includes about 3,481,780 kg CO2e from Scope 1 emissions, which primarily stem from direct operations, and approximately 377,330 kg CO2e from Scope 2 emissions related to purchased electricity. The previous year, 2022, saw total emissions of about 965,930 kg CO2e, with Scope 1 emissions at approximately 620,220 kg CO2e and Scope 2 emissions at around 345,710 kg CO2e. This indicates a significant increase in emissions from 2022 to 2023. In 2021, the company reported total emissions of about 858,350 kg CO2e, with Scope 1 emissions at approximately 526,450 kg CO2e and Scope 2 emissions at around 331,900 kg CO2e. The trend shows a substantial rise in emissions over the years, with 2020 emissions recorded at about 831,260 kg CO2e. Despite the increasing emissions, there are currently no disclosed reduction targets or climate pledges from IVD Medical Holding. The company has not committed to any specific science-based targets for emissions reduction, which places it in a challenging position within the industry context of growing climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 434,060 | 000,000 | 000,000 | 0,000,000 |
| Scope 2 | 397,200 | 000,000 | 000,000 | 000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ivd Medical Holding is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
